Today, Fort Worth-based life sciences company Source Explorer made a big announcement: its new service is emerging from the soft launch phase, accompanied by what the company is calling the “industry’s most-effective platform for linking project owners and service providers.”
Dubbed the “eharmony of the pharmaceutical industry” for its search-and-matching service, the woman-owned tech company aims to connect life science professionals with the specialty suppliers they need.
When looking for a supplier, life science professionals typically turn to Google, their own personal network, a talent search, or an internal source. Narrowing down long lists of providers, as well as dealing with middlemen or potential delays in communication, can make the process slow and inefficient.
However, Source Explorer’s newly launched search engine allows individuals in the fields of pharma, biotech, or medical devices to browse a broad spectrum of potential service providers and connect with them in minutes. Source Explorer focuses solely on the life science industry, and every listed supplier is vetted first.
Founder and CEO Kellan Barfield said in the announcement that the service will help save clients months of lost time, as only the most qualified suppliers will get hired for the needed roles.
“Every hour someone spends trying to find a new agency or vendor, that is an hour taken away from figuring out how to get great products in the hands of the right patients,” she said. “I am here to give them that time back.”
How it works
Suppliers pay Source Explorer a fee in order to be listed. Depending on their plan, they may also have access to valuable webinars, networking opportunities, “spotlight” content positioning on the website, and additional benefits.
Life science professionals are able to use Source Explorer free of charge. By sorting the providers into specific categories and sub-disciplines, the engine ensures that only relevant search results are returned. Also, users can read reviews left by client companies on the suppliers’ listings.
Other key Source Explorer features include: detailed tracking of client activity, a viewing tool to showcase the supplier’s portfolio, and an internal messaging conduit.
Built with expertise
Coinciding with the new service announcement, Source Explorer released that it had accumulated over 3,000 clients. With some of life science’s leading industry players in its portfolio—Gilead, AstraZeneca, Roche, Mylan, Biogen, Genentech—the company is poised to take its spot in the global marketplace.
With over two decades of experience in the biotech and pharmaceutical industries, Barfield knows firsthand the importance of working with the right partners.
As the Head of Commercial Excellence for Gilead Sciences prior to founding Source Explorer, she collaborated with professionals across nineteen countries to lead initiatives in training, leadership development, sales, and coaching. Barfield also spent fourteen years at Alcon, where she not only led the growth of a $375M portfolio, but also served as the head of Global Performance Development.
With Source Explorer, Barfield hopes to create greater efficiency for individuals working in the life sciences and increase the visibility of the industry as a whole.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
The summit is an innovation multiplier for capital, collaboration, and commercialization. Plus, you can meet 2021 NTX Rising Stars—and the new companies moving to BioLabs at Pegasus Park. Here's an updated agenda for the annual iC3 Life Science Summit on September 30 and October 1.
-
Deadline for nominations is Friday, September 17. The 2021 award, sponsored by BioLabs at Pegasus Park, will be presented on September 30 at the iC3 Life Science Summit. The impact that Dr. Dennis K. Stone left on the DFW biotech industry is, without doubt, immeasurable, says BioNTX. Past recipients of the award that honors his memory are Phil Ralston, Lyda Hill, Darlene Boudreaux, Paul Dorman, and Hubert Zajicek.
-
The eighth annual IC3 Summit will be a forum for leaders from startups to large multinationals in the biotech, pharma, healthcare, and academic communities. A key summit speaker will be Admiral Brett Giroir, M.D., the former White House COVID-19 "testing czar."
-
Rare is not that rare, says the RDCC. One in ten people lives with a rare disease, and the new coalition will unify life science companies dedicated to developing treatments. The goal? To inform policymakers of the unique challenges in the space. Signature Biologics joins Dallas-based Taysha as a member of the RDCC.
-
With the "significantly oversubscribed" fund round, Sole Source now has over $1 billion under management. It's already made investments in three portfolio companies through the new fund: Dallas Plastics, Peak Technologies, and I.D. Images. Founder and CEO David Fredston says his firm's "investment process and commitment to human capital can deliver great results."
